Subtitle
Acute Toxicities After Proton Beam Therapy Following Breast-Conserving Surgery for Breast Cancer: Multi-institutional Prospective PCG Registry Analysis. This is the report of the prospective multi-institutional Proton Collaborative Group registry study.
Subtitle
Acute Toxicities After Proton Beam Therapy Following Breast-Conserving Surgery for Breast Cancer: Multi-institutional Prospective PCG Registry Analysis. This is the report of the prospective multi-institutional Proton Collaborative Group registry study.
Proto therapy Time
April 2020
Executive summary
82 patients received PBT and their adverse events (AEs) were recorded prospectively at each institution. Median follow-up was 8.1 months. Median dose was 50.4 Gy in 28 fractions. 90% patients received a lumpectomy bed boost and 83% patients received regional nodal irradiation. Six patients (7.3%) experienced grade 3 AEs (5 with dermatitis, 5 with breast pain). Body mass index (BMI) was associated with grade 3 dermatitis (P = .015). Fifty-eight patients (70.7%) experienced grade ≥2 dermatitis.
The authors concluded that PBT including RNI after BCS is well-tolerated. Elevated BMI is associated with grade 3 dermatitis.
Top cancer treatments
Related contents
Proton Therapy Publication
October 2024
Proton therapy for breast cancer: Reducing toxicity.
Proton Therapy Publication
September 2024
PTCOG international survey of practice patterns and trends in utilization of proton therapy for breast cancer.
Proton Therapy Publication
September 2024
Reducing Radiation Dermatitis for PBS Proton Therapy Breast Cancer Patients Using SpotDelete.
Proton Therapy Publication
September 2024
Dose Deintensified 3-Day Photon, Proton, or Brachytherapy: A Nonrandomized Controlled Partial Breast Irradiation Trial.
Proton Therapy Publication
October 2024
Revision Surgeries After Proton vs Photon Postmastectomy Radiation Therapy in Prepectoral Implant-Based Breast Reconstruction.
Proton Therapy Publication
June 2024
Dosimetric Correlation of Acute Radiation Dermatitis in Patients With Breast Cancer Undergoing Hypofractionated Proton Beam Therapy Using Pencil Beam Scanning.
Proton Therapy Publication
July 2024
Proton therapy reduces the effective dose to immune cells in breast cancer patients.
Proton Therapy Publication
May 2023
Outcomes of Patients Treated in the UK Proton Overseas Programme: Non-central Nervous System Group.